共 125 条
[1]
Witjes JA(2021)European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines Eur Urol 79 82-104
[2]
Bruins HM(2003)Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis Lancet 361 1927-1934
[3]
Cathomas R(2005)Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration Eur Urol 48 202-206
[4]
Compérat EM(2004)Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis J Urol 171 561-569
[5]
Cowan NC(2016)Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis Oncologist 21 708-715
[6]
Gakis G(2014)Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database Urology 83 75-80
[7]
Advanced Bladder Cancer Meta-analysis Collaboration E(2016)Perioperative treatment and radical cystectomy for bladder cancer—a population based trend analysis of 10,338 patients in the Netherlands Eur J Cancer 54 18-26
[8]
Advanced Bladder Cancer Meta-analysis Collaboration TS(2019)Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer Cancer Med 8 6258-6271
[9]
Winquist R(2020)Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients BMC Urol 20 158-e94
[10]
Kirchner J(2017)Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis Clin Invest Med 40 E81-1459